Publications by authors named "Ralf D Hofheinz"

Claim this Profile
H
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments.
Magdalena K Scheck, Ralf D Hofheinz, Sylvie Lorenzen

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and newly approved cancer drugs - A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumors.
Leonie Rabe, Frederik Wenz, Michael Ehmann, Frank Lohr, Ralf Dieter Hofheinz

Radiother Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.
Emmanouil Fokas, Ane Appelt, Robert Glynne-Jones, Geerard Beets, Rodrigo Perez, Ralf D Hofheinz

Nat Rev Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society.
Ulrike Irmgard Attenberger, Stephan Clasen, Michael Ghadimi, Ulrich Grosse, Gerald Antoch, Ralf Dieter Hofheinz

Rofo· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types.
Daniel Buergy, Julian Riedel, Gustavo R Sarria, Michael Ehmann, Davide Scafa, Ralf D Hofheinz

Int J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.
Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, Timothy Price, Ralf D Hofheinz

J Clin Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology.
Anna Hohneck, Stephanie Rosenkaimer, Tina Sieburg, Jakob Holzwarth, Ralf D Hofheinz

Anticancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, Thorsten O Goetze, Johannes Meiler, Ralf D Hofheinz

Lancet· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, Alberto Sobrero, Maria Banzi, Ralf Dieter Hofheinz

Oncologist· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT.
Kirsten Merx, Uwe M Martens, Melanie Kripp, Thomas Hoehler, Michael Geissler, Ralf D Hofheinz

Int J Radiat Oncol Biol Phys· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, Gerald Illerhaus, Uwe M Martens, Ralf D Hofheinz

JAMA Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative.
Johannes Betge, Ana Barat, Verena Murphy, Thomas Hielscher, Nicole C Van Grieken, Ralf D Hofheinz

Digestion· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Salah-Eddin Al-Batran, Ralf D Hofheinz, Claudia Pauligk, Hans-Georg Kopp, Georg Martin Haag

Lancet Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.
Stefan Haneder, Johannes Michael Budjan, Stefan Oswald Schoenberg, Simon Konstandin, Lothar Rudi Schad, Ralf Dieter Hofheinz

Strahlenther Onkol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.
Xabier García-Albéniz, Rosa Gallego, Ralf Dieter Hofheinz, Gloria Fernández-Esparrach, Juan Ramón Ayuso-Colella

World J Gastroenterol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).
Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, Jörg T Hartmann, Markus Moehler, Ralf D Hofheinz

Eur J Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.
Joerg Thomas Hartmann, Karin Oechsle, Elke Jäger, Hans Edgar Reis, Cornelie Haag, Ralf D Hofheinz

Anticancer Drugs· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis